Epidermodysplasia verruciformis is a rare, heritable disease characterized by an unusual susceptibility to infection with specific types of human papillomavirus and a propensity for developing malignant skin tumours. Partial defects in cell-mediated immunity have been demonstrated in this disease. In the present report, a young patient with epidermodysplasia verruciformis who was treated successfully with surgical treatment is described.
LewandowskyF, LutzW. Ein Fall einer bisher nicht beschriebenen Hauterkrankungn (Epidermodysplasia verruciformis).Arch Dermatol Syphilol1922; 12: 306-16.
RamozN, TaiebA, RuedaLEvidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21–p24 and 17q25.J Invest Dermatol2000; 114: 1148-53.
4.
BogdanI, SecharerL, RüdlingerREpidermodysplasia verruciformis in two brothers developing aggressive squamous cell carcinoma.Dermatol Surg2007; 33: 1525-8.
5.
SeguraS, CarreraC, FerrandoJDermascopy in epidermodisplasia verruciformis.Dermatol Surg2006; 32: 103-6.
6.
MajewskiS, JablonskaS. Epidermodysplasia verruciformis of a model of human papillomavirus-induced genetic cancer of the skin.Arch Dermatol1995; 131: 1312-8.
AnadoluR, OskayT, ErdemC, BoyvatA, TerziE, GürgeyE. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.J Am Acad Dermatol2001; 45: 296-9.
9.
HuW, NuovoG, WillenM, SomachS. Epidermodysplasia verruciformis in two half brothers with HIV infection.J Cutan Med Surg2004; 8: 357-60.
10.
BerthelotC, DickersonM, RadyPTreatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.J Am Acad Dermatol2007; 56: 882-6.
11.
OliveiraWR, NetoCF, RivittiEA. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis.J Am Acad Dermatol2004; 50: e14.
